Nutrition of children up to one year of age what public health topic von Zemanová, M, Mičíková, L, Petráková, A, Hujová, A, Váverková, B, Puhlová, E, Vostrý, M, Cmorej, P, Lulková, M, Rothová, M

Volltext

Prediction of Disease Progression Using Mutational Screening in Patients with Myelodysplastic Syndrome von Belickova, M, Vesela, J, Votavova, H, Vostry, M, Jonasova, A, Zemanova, Z, Brezinova, J, Cermak, J

Volltext

High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients von Fuchs, O, Polak, J, Bokorova, R, Kostecka, A, Vostry, M, Neuwirtova, R, Siskova, M, Stopka, T, Lauermannova, M, Maaloufova, J. Soukupova, Salek, C, Mikulenkova, D, Cermak, J, Brezinova, J, Zemanova, Z, Michalova, K, Jonasova, A

Volltext

MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels von Fuchs, O, Polak, J, Bokorova, R, Kostecka, A, Vostry, M, Jonasova, A, Myslivcova, D, Siskova, M, Stopka, T, Lauermannova, M, Salek, C, Maaloufova, J. Soukupova, Mikulenkova, D, Cermak, J, Brezinova, J, Zemanova, Z, Michalova, K, Neuwirtova, R

Volltext

P-106 Prognostic significance of NPM1, CEBPA, and MLL-PTDs mutations, EVI1, MN1 and ERG expressions in MDS and AML treated with azacitidine von Jonasova, A, Kostecka, A, Vostry, M, Neuwirtova, R, Fuchs, O

Volltext

42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA von Fuchs, O, Polak, J, Bokorova, R, Vostry, M, Kostecka, A, Hajkova, H, Neuwirtova, R, Siskova, M, Cermak, J, Sponerova, D, Lauermannova, M, Soukupova, J, Cervinek, L, Brezinova, J, Michalova, K, Jonasova, A

Volltext

P-231 The role of Fli1 and p53 for the effective megakaryopoiesis in 5q-syndrome von Neuwirtova, R, Stritesky, J, Fuchs, O, Vostry, M, Kostecka, A, Siskova, M, Michalova, K, Jonasova, A

Volltext

Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling von Kaisrlikova, M., Vesela, J., Vostry, M., Votavova, H., Kundrat, D., Merkerova, M. Dostalova, Lauermannova, M., Maaloufova, J. Soukupova, Zemanova, Z., Jonasova, A., Cermak, J., Belickova, M.

Volltext

P24 - Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: MUTATIONS IN RUNX1 GENE CONTRIBUTE TO THE PROGRESSION OF LOWER-RISK MDS PATIENTS BY DISRUPTING CELLU... von Kaisrlikova, M., Vesela, J., Vostry, M., Votavova, H., Kundrat, D., Merkerova, M. Dostalova, Lauermannova, M., Maaloufova, J. Soukupova, Zemanova, Z., Jonasova, A., Cermak, J., Belickova, M.

Volltext

274 The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatment von Jonasova, A, Fuchs, O, Vostry, M, Holicka, M, Kostecka, A, Cermak, J, Caniga, M, Kobylka, P, Siskova, M, Cervinek, L, Belohlavkova, P, Sykora, M, Zemanova, Z, Michalova, K, Brezinova, J, Neuwirtova, R

Volltext

250 Are Fli1, EKLF, PU.1, HDM2 and TP53 factors implicated in refractory anemia and megakaryopoiesis in 5q- syndrome? von Neuwirtova, R, Fuchs, O, Jonasova, A, Holicka, M, Vostry, M, Kostecka, A, Hajkova, H, Cermak, J, Vondrakova, J, Hochova, I, Siskova, M, Libiger, J, Sponerova, D, Kadlckova, E, Novakova, L, Cerna, O, Cmejla, R, Pospisilova, D, Brezinova, J, Zemanova, Z, Michalova, K, Seifertova, N

Volltext

237 - Prediction of Disease Progression Using Mutational Screening in Patients with Myelodysplastic Syndrome von Belickova, M., Vesela, J., Votavova, H., Vostry, M., Jonasova, A., Zemanova, Z., Brezinova, J., Cermak, J.

Volltext

228 - MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels von Fuchs, O., Polak, J., Bokorova, R., Kostecka, A., Vostry, M., Jonasova, A., Myslivcova, D., Siskova, M., Stopka, T., Lauermannova, M., Salek, C., Maaloufova, J. Soukupova, Mikulenkova, D., Cermak, J., Brezinova, J., Zemanova, Z., Michalova, K., Neuwirtova, R.

Volltext

227 - High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients von Fuchs, O., Polak, J., Bokorova, R., Kostecka, A., Vostry, M., Neuwirtova, R., Siskova, M., Stopka, T., Lauermannova, M., Maaloufova, J. Soukupova, Salek, C., Mikulenkova, D., Cermak, J., Brezinova, J., Zemanova, Z., Michalova, K., Jonasova, A.

Volltext

ADIPOCYTOKINES AND OTHER SURVIVAL PREDICTORS IN HEMODIALYSIS (HD) PATIENTS WITH METABOLIC SYNDROME (MS) von Vostry, M., Rajdl, D., Eiselt, J., Malanova, L., Pikner, R., Trefil, L., Racek, J.

Volltext

Genetic and non-genetic effects influencing lamb survivability in the Czech Republic von Vostrý, L., Milerski, M.

Volltext

Contribution of domestic production records, Interbull estimated breeding values, and single nucleotide polymorphism genetic markers to the single-step genomic evaluation of milk p... von Přibyl, J., Madsen, P., Bauer, J., Přibylová, J., Šimečková, M., Vostrý, L., Zavadilová, L.

Volltext

Genetic contribution of ram on litter size in Šumava sheep von Schmidova, Jitka, Milerski, Michal, Svitakova, Alena, Vostry, Lubos

Volltext

Estimation of genetic parameters and evaluation of test-day milk production in sheep von Bauer, J., Vyzkumny Ustav Zivocisne Vyroby, Prague (Czech Republic), Milerski, M., Vyzkumny Ustav Zivocisne Vyroby, Prague (Czech Republic), Pribyl, J., Vyzkumny Ustav Zivocisne Vyroby, Prague (Czech Republic), Vostry, L., Vyzkumny Ustav Zivocisne Vyroby, Prague (Czech Republic)

Volltext

Genetic diversity and effect of inbreeding on litter size of the Romanov sheep von Vostry, L., Milerski, M., Schmidova, J., Vostra-Vydrova, H.

Volltext